Could a common antacid help speed up labor?
NCT ID NCT06580782
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study is testing whether calcium carbonate, a common antacid, can safely improve contractions during labor induction or augmentation. Researchers will enroll 60 first-time mothers at 36+ weeks of pregnancy. The main goal is to see if a larger trial is possible, not yet to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR DYSTOCIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
calcium carbonate
What this could lead to
If it works, this could offer a simple, low-cost way to help labor progress and reduce the need for higher doses of synthetic oxytocin.
What could go wrong
This is a small feasibility study (60 people), not yet designed to prove effectiveness. The main goal is to see if a larger trial is possible, so results may not be conclusive.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.